Related Experiment Video
Updated: Mar 22, 2026

21:16
An In Vitro Skin Irritation Test SIT using the EpiDerm Reconstructed Human Epidermal RHE Model
Published on: July 13, 2009
69.3K
[Evaluation criteria for rat skin anaphylactoid test]
Summary
This study introduces the K value, a new criterion for the rat skin anaphylactoid test. This method offers a more objective and accurate evaluation of anaphylactoid reactions compared to traditional approaches.
Area of Science:
- Pharmacology
- Toxicology
- Immunology
Background:
- The rat skin anaphylactoid test is a common method for evaluating drug-induced anaphylactoid reactions.
- Existing evaluation criteria, such as blue spot diameter, may lack objectivity and be influenced by individual animal factors.
Purpose of the Study:
- To explore characteristic indexes for evaluating the rat skin anaphylactoid test.
- To define and validate the K value as a novel evaluation criterion.
Main Methods:
- Comparing optical density (OD) values of skin blue spots at treated and control sites within the same animal.
- Utilizing common contrast agents, traditional Chinese medicine injections, and active pharmaceutical ingredients/excipients as test drugs.
- Defining the K value based on OD ratios to classify reactions as positive, doubtable, or negative.
Main Results:
- The K value effectively minimizes errors caused by individual animal variations.
- The K value's three-level criteria (positive, doubtable, negative) are more objective and accurate than two-level diameter criteria.
- The K value evaluation aligns with and potentially improves upon classic criteria for assessing anaphylactoid reactions.
Conclusions:
- The K value serves as a more reliable and accurate evaluation criterion for the rat skin anaphylactoid test.
- This novel approach enhances the objectivity and precision of anaphylactoid reaction assessment in preclinical studies.
- The K value method is applicable for evaluating various test drugs, including those from traditional Chinese medicine.
Related Concept Videos
Allergic Reactions: Anaphylaxis
142
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
142
Allergic Reactions
33.4K
Overview
33.4K
Drug Toxicity: Allergic Reactions
126
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
126
Hypersensitivity Reactions: Immune-Complex Reactions
127
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
127
Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
160
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
160

